This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Verena Litty: Innovator in Monoclonal Antibodies
Introduction
Verena Litty is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies.
Latest Patents
Verena holds a patent for "Human monoclonal antibodies to the islet cell antigen IA-2." This invention involves human monoclonal antibodies targeting the islet cell antigen IA-2. The patent outlines a process for producing these antibodies, their use in detecting antibodies to IA-2, and methods for identifying the islet cell antigen IA-2 in various samples. She has 1 patent to her name.
Career Highlights
Verena Litty is currently employed at Roche Diagnostics Operations, Inc., where she continues to advance her research and innovations in the field of diagnostics. Her work has been instrumental in enhancing the understanding and detection of autoimmune conditions.
Collaborations
Throughout her career, Verena has collaborated with notable colleagues, including Suzanne Elisabeth Berlo and Josef Endl. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.
Conclusion
Verena Litty's contributions to the field of monoclonal antibodies exemplify her dedication to advancing medical science. Her innovative work continues to impact the diagnostics industry positively.